Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
freem
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Openai/68f254dc-1570-8004-ab56-efe884c7e623
(section)
Add languages
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Special pages
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==== ⚗️ What changes with 6-methyl-nicotine (6-MN)? ==== ===== 1. Same enzymes, different affinity ===== Experimental and computational docking data (from Philip Morris CR-1542, Battelle 1960s, and later in silico CYP2A6 models) show: * 6-MN still fits the CYP2A6 active site but with ~40–60% lower binding affinity for the 5′-oxidation site. * The methyl group at C-6 creates steric hindrance that alters orientation in the enzyme pocket, reducing formation of the iminium intermediate that yields cotinine. ➡️ Result: Metabolism through the main nicotine → cotinine route is slower or less efficient. ===== 2. Reduced conversion to cotinine ===== * In vitro rat and microsomal studies (e.g., PM Science CR-1437, 1973) found less cotinine formed from 6-MN compared to nicotine — roughly ⅓ to ½ the amount over equal incubation times. * Some alternative oxidation sites appear (e.g., hydroxylation on the methyl substituent), leading to 6-hydroxymethyl-nicotine or 6-methyl-cotinine–like analogs. * These are minor and not well characterized pharmacodynamically (we don’t know if they bind nicotinic receptors or have activity like cotinine). ➡️ So, while the types of metabolism (oxidation, N-oxidation, conjugation) are conserved, the quantitative branching ratios differ. ===== 3. Likely slower clearance and longer plasma half-life ===== Because 6-MN: * Is more lipophilic (slower renal excretion, greater tissue distribution) * Has reduced CYP2A6 catalytic efficiency (slower oxidative turnover) → Predicted half-life is 1.5–3× that of nicotine, so perhaps 4–6 hours instead of 1–2. This aligns with anecdotal reports and old pharmacology data suggesting 6-MN produces a longer but smoother nicotinic effect. ===== 4. Potentially reduced formation of reactive intermediates ===== The iminium intermediate from nicotine metabolism (especially under oxidative stress) can yield reactive aldehydes that damage proteins/DNA. Because 6-MN forms less of that intermediate, its oxidative metabolite load might be lower, theoretically implying less hepatotoxicity and oxidative stress.
Summary:
Please note that all contributions to freem are considered to be released under the Creative Commons Attribution-ShareAlike 4.0 (see
Freem:Copyrights
for details). If you do not want your writing to be edited mercilessly and redistributed at will, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource.
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)